$ACT Headlines 10 biggest S&P 500 winners and
Post# of 72709
Posted On: 07/10/2014 9:51:57 AM
$ACT Headlines
10 biggest S&P 500 winners and losers for 2014 10:44 a.m. July 1, 2014 - Philip van Doorn
Affiliated Managers Group to join S&P 500 5:33 p.m. June 24, 2014 - Wallace Witkowski
10 best-performing S&P 500 stocks of 2014 2:38 p.m. June 2, 2014 - Philip van Doorn
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - Russ Britt
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
Mylan to start selling generic Celebrex in May 7:23 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - Russ Britt
Staples awash in red; eBay up as Icahn posts new letter 5:09 p.m. March 6, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 12:12 p.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 12:21 p.m. Feb. 20, 2014 - Russ Britt
Actavis swings to loss on charges, write-downs 9:04 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 2:59 p.m. Feb. 19, 2014 - Russ Britt
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 12:03 p.m. Feb. 19, 2014 - Russ Britt
Synergy Pharmaceuticals' Plecanatide to Move into Phase III - Analyst Blog 5:10 p.m. July 9, 2014 - Zacks.com
InsiderInsights.com Daily Round Up: 7/7/14 1:21 p.m. July 8, 2014 - Seeking Alpha
M&A Activity Hits 7-Year Peak: Next 3 Takeover Targets - Analyst Blog 12:29 p.m. July 7, 2014 - Zacks.com
Will 2014’s Top Performers Keep Performing? 2:01 a.m. July 6, 2014 - InvestorPlace.com
Impax Acquires Generic Products from Actavis - Analyst Blog 12:00 p.m. July 3, 2014 - Zacks.com
Teva files a citizen petition regarding approvability of generic versions of Copaxone 8:28 a.m. July 3, 2014 - Seeking Alpha
What Stocks Top Funds Are Buying Now 6:09 p.m. July 2, 2014 - Investors Business Daily
Taro Pharmaceuticals: Last Week's Move Is Only The Beginning 9:05 a.m. July 2, 2014 - Seeking Alpha
Allergan Can Go It Alone 6:09 a.m. July 2, 2014 - Barrons.com
Why Actavis (ACT) Stock May Move Higher Today 8:42 a.m. July 1, 2014 - TheStreet.com
Actavis, Forest To Sell or Relinquish Generics Rights 5:34 p.m. June 30, 2014 - The Wall Street Journal Interactive Edition
Actavis Says Holders of 73% of Forest Shares Elect Stock 9:29 a.m. June 30, 2014 - The Wall Street Journal Interactive Edition
Many IBD 50 Stocks Struggle To Climb After Breakouts 6:08 p.m. June 27, 2014 - Investors Business Daily
Auxilium and QLT to Merge on Tax Saving Attractions - Analyst Blog 12:10 p.m. June 27, 2014 - Zacks.com
Orexo sues Actavis over Zubsolv patent 10:48 a.m. June 27, 2014 - Seeking Alpha
Top Analyst Upgrades and Downgrades: Alcoa, Cigna, Intel, Molina, Teva, UnitedHealth and More 7:27 a.m. June 27, 2014 - 247WallSt.com
Why These 5 Mutual Funds Are Beating the S&P 500 5:34 a.m. June 27, 2014 - InvestorPlace.com
Novo, Other Medicals Display Healthy Action 5:41 p.m. June 26, 2014 - Investors Business Daily
Diamond Hill Capital Comments on Actavis Inc 10:49 a.m. June 26, 2014 - GuruFocus.com
Ampyra faces generic threat 7:11 a.m. June 26, 2014 - Seeking Alpha
Actavis Confirms Generic Ampyra® Patent Challenge 4:05 p.m. July 8, 2014 - PR Newswire - PRF
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 5:30 a.m. July 4, 2014 - PR Newswire - PRF
Impax Acquires Two Products from Actavis 4:05 p.m. July 2, 2014 - PR Newswire - PRF
Actavis Completes Acquisition of Furiex Pharmaceuticals 8:46 a.m. July 2, 2014 - PR Newswire - PRF
Actavis Announces Final Stockholder Merger Consideration Election Results in Connection with Forest Laboratories Acquisition 8:00 a.m. July 2, 2014 - PR Newswire - PRF
Furiex Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger 3:15 p.m. July 1, 2014 - BusinessWire - BZX
Fitch Rates Forest Labs Bonds 'BBB-', Affirms Actavis at 'BBB-'; Outlook Stable 10:08 a.m. July 1, 2014 - BusinessWire - BZX
Actavis plc Appoints New Members and Announces Changes to Board of Directors Following Close of Forest Laboratories, Inc. Acquisition 9:00 a.m. July 1, 2014 - PR Newswire - PRF
Actavis Completes Forest Laboratories Acquisition 8:20 a.m. July 1, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - PR Newswire - PRF
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - PR Newswire - PRF
Actavis to Host Second Quarter 2014 Earnings Conference Call and Webcast 8:00 a.m. June 30, 2014 - PR Newswire - PRF
Actavis Confirms Generic Zubsolv® Patent Challenge 7:30 a.m. June 30, 2014 - PR Newswire - PRF
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Affiliated Managers Group Set to Join S&P 500; LaSalle Hotel Properties, Rayonier Advanced Materials, TimkenSteel, Belden to Join the S&P MidCap 400; Others to Join S&P SmallCap 600 6:50 p.m. June 24, 2014 - PR Newswire - PRF
Actavis and Forest Announce Tentative Election Deadline of June 27, 2014 8:30 a.m. June 24, 2014 - BusinessWire - BZX
Actavis and Forest Announce Tentative Election Deadline Of June 27, 2014 8:30 a.m. June 24, 2014 - PR Newswire - PRF
10 biggest S&P 500 winners and losers for 2014 10:44 a.m. July 1, 2014 - Philip van Doorn
Affiliated Managers Group to join S&P 500 5:33 p.m. June 24, 2014 - Wallace Witkowski
10 best-performing S&P 500 stocks of 2014 2:38 p.m. June 2, 2014 - Philip van Doorn
Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - Russ Britt
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - Russ Britt
Mylan to start selling generic Celebrex in May 7:23 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - Russ Britt
Staples awash in red; eBay up as Icahn posts new letter 5:09 p.m. March 6, 2014 - Sue Chang
Icahn Enterprises reports profit up 144% in 2013 11:23 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 12:12 p.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 5:46 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 6:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 12:21 p.m. Feb. 20, 2014 - Russ Britt
Actavis swings to loss on charges, write-downs 9:04 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 2:59 p.m. Feb. 19, 2014 - Russ Britt
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 12:03 p.m. Feb. 19, 2014 - Russ Britt
Synergy Pharmaceuticals' Plecanatide to Move into Phase III - Analyst Blog 5:10 p.m. July 9, 2014 - Zacks.com
InsiderInsights.com Daily Round Up: 7/7/14 1:21 p.m. July 8, 2014 - Seeking Alpha
M&A Activity Hits 7-Year Peak: Next 3 Takeover Targets - Analyst Blog 12:29 p.m. July 7, 2014 - Zacks.com
Will 2014’s Top Performers Keep Performing? 2:01 a.m. July 6, 2014 - InvestorPlace.com
Impax Acquires Generic Products from Actavis - Analyst Blog 12:00 p.m. July 3, 2014 - Zacks.com
Teva files a citizen petition regarding approvability of generic versions of Copaxone 8:28 a.m. July 3, 2014 - Seeking Alpha
What Stocks Top Funds Are Buying Now 6:09 p.m. July 2, 2014 - Investors Business Daily
Taro Pharmaceuticals: Last Week's Move Is Only The Beginning 9:05 a.m. July 2, 2014 - Seeking Alpha
Allergan Can Go It Alone 6:09 a.m. July 2, 2014 - Barrons.com
Why Actavis (ACT) Stock May Move Higher Today 8:42 a.m. July 1, 2014 - TheStreet.com
Actavis, Forest To Sell or Relinquish Generics Rights 5:34 p.m. June 30, 2014 - The Wall Street Journal Interactive Edition
Actavis Says Holders of 73% of Forest Shares Elect Stock 9:29 a.m. June 30, 2014 - The Wall Street Journal Interactive Edition
Many IBD 50 Stocks Struggle To Climb After Breakouts 6:08 p.m. June 27, 2014 - Investors Business Daily
Auxilium and QLT to Merge on Tax Saving Attractions - Analyst Blog 12:10 p.m. June 27, 2014 - Zacks.com
Orexo sues Actavis over Zubsolv patent 10:48 a.m. June 27, 2014 - Seeking Alpha
Top Analyst Upgrades and Downgrades: Alcoa, Cigna, Intel, Molina, Teva, UnitedHealth and More 7:27 a.m. June 27, 2014 - 247WallSt.com
Why These 5 Mutual Funds Are Beating the S&P 500 5:34 a.m. June 27, 2014 - InvestorPlace.com
Novo, Other Medicals Display Healthy Action 5:41 p.m. June 26, 2014 - Investors Business Daily
Diamond Hill Capital Comments on Actavis Inc 10:49 a.m. June 26, 2014 - GuruFocus.com
Ampyra faces generic threat 7:11 a.m. June 26, 2014 - Seeking Alpha
Actavis Confirms Generic Ampyra® Patent Challenge 4:05 p.m. July 8, 2014 - PR Newswire - PRF
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 5:30 a.m. July 4, 2014 - PR Newswire - PRF
Impax Acquires Two Products from Actavis 4:05 p.m. July 2, 2014 - PR Newswire - PRF
Actavis Completes Acquisition of Furiex Pharmaceuticals 8:46 a.m. July 2, 2014 - PR Newswire - PRF
Actavis Announces Final Stockholder Merger Consideration Election Results in Connection with Forest Laboratories Acquisition 8:00 a.m. July 2, 2014 - PR Newswire - PRF
Furiex Stockholders Approve Acquisition by Actavis; Ukrainian Antimonopoly Committee Clears Proposed Merger 3:15 p.m. July 1, 2014 - BusinessWire - BZX
Fitch Rates Forest Labs Bonds 'BBB-', Affirms Actavis at 'BBB-'; Outlook Stable 10:08 a.m. July 1, 2014 - BusinessWire - BZX
Actavis plc Appoints New Members and Announces Changes to Board of Directors Following Close of Forest Laboratories, Inc. Acquisition 9:00 a.m. July 1, 2014 - PR Newswire - PRF
Actavis Completes Forest Laboratories Acquisition 8:20 a.m. July 1, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Actavis and Forest Receive U.S. FTC Clearance for Actavis’ Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Forest 5:15 p.m. June 30, 2014 - PR Newswire - PRF
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - BusinessWire - BZX
Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results 8:30 a.m. June 30, 2014 - PR Newswire - PRF
Actavis to Host Second Quarter 2014 Earnings Conference Call and Webcast 8:00 a.m. June 30, 2014 - PR Newswire - PRF
Actavis Confirms Generic Zubsolv® Patent Challenge 7:30 a.m. June 30, 2014 - PR Newswire - PRF
Leadership Appointments, Approved Acquisitions, Licensing Agreements, Technical UPdate, and Response to Tender Offer Announcement - Analyst Notes on Actavis, Forest, Vertex, MannKind and Gentiva 5:20 a.m. June 26, 2014 - PR Newswire - PRF
Affiliated Managers Group Set to Join S&P 500; LaSalle Hotel Properties, Rayonier Advanced Materials, TimkenSteel, Belden to Join the S&P MidCap 400; Others to Join S&P SmallCap 600 6:50 p.m. June 24, 2014 - PR Newswire - PRF
Actavis and Forest Announce Tentative Election Deadline of June 27, 2014 8:30 a.m. June 24, 2014 - BusinessWire - BZX
Actavis and Forest Announce Tentative Election Deadline Of June 27, 2014 8:30 a.m. June 24, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼